Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Product differentiation
Distinctions between products in the same market based on different attributes the products hold. This distinction can be both positive and negative.
Product differentiation can be a method of competitive dominance. However if this research into the market results in altering a product to affect improvement, these changes are not the product differentiation. Product differentiation is the method of characterising the differences between products or services, or the subsequent record of differences. This is implemented to demonstrate the specific aspects of a company's product and develop a perception of value.
See also:
Product attributes
Product class
Marketing advantage
Related terms
Market value added (MVA), Research proposal, Franchising, Cause-related marketing , Focus group moderator, Penetration pricing, Customised marketing mix, Syndicated market research data, Offensive marketing, List broker, Unprompted recall, Ad rotation, Positioning, SWOT analysis, Executive summary,
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- AstraZeneca and Innate Pharma to end study on immuno-oncology drug monalizumab
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- bluebird bio reveals plans to launch two gene therapies
- Roche’s Tecentriq demonstrates positive phase 3 results as a subcutaneous injection
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Strategic commitment
- Pfizer set to acquire Global Blood Therapeutics in deal worth $5.4bn
- AstraZeneca and Daiichi Sankyo get FDA approval for breast cancer drug
- NHS England launches hepatitis C screening scheme to reach 2030 elimination goal
- Bayer’s Nubeqa receives FDA approval to treat metastatic prostate cancer
- Valneva and Pfizer initiate phase 3 Lyme disease vaccine study
- Medmeme appoints Dr Joseph Laudano to medical affairs role
- Gilead announces positive Biktarvy data for HIV and hepatitis B
- Roche’s Tecentriq demonstrates positive phase 3 results as a subcutaneous injection
- Sarepta to submit application for Duchenne muscular dystrophy gene therapy
- Achieving communication excellence by targeting the right channel at the right time
- Successful product commercialisation: what can we learn from the rare disease setting?
PMHub
COUCH Health
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...
